MedPath

Efficacy of rTMS in the Treatment of Patients With Migraine

Not Applicable
Conditions
Migraine
Registration Number
NCT00316979
Lead Sponsor
Taipei Veterans General Hospital, Taiwan
Brief Summary

Migraine is a condition thought to be related to cortical hyperexcitability. Repetitive transcranial magnetic stimulation (rTMS) can modulate the cortical excitability by means of long-term potentiation or long-term depression. This study will will test the safety and efficacy of rTMS in the treatment of patients with Migraine.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Age of 18-65 years
  • Diagnosed as migraine (with or without aura)
  • More than 4 attacks per month for at least 3 months prior to study
  • No preventive medication used
  • Must be able to sign permit
Exclusion Criteria
  • History of seizure or family history of seizures
  • Women in pregnancy or breast-feeding
  • Patient with medication overuse
  • Patient with other medical, psychologic, or surgical illness
  • Patient under preventive medications
  • Prior rTMS examination one month within

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Reduction in days of migraine attack per month
Secondary Outcome Measures
NameTimeMethod
The reduction in dosage of acute abortive medication
The reduction of headache index

Trial Locations

Locations (1)

Headache Center, Teipei Veterans General Hospital

🇨🇳

Taipei, Taiwan

© Copyright 2025. All Rights Reserved by MedPath